MARIA ROLDAN BUSTINZA: Open Payments
NPI 1972010742 · WYOMING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$671 in 9 payments from 7 companies in 2025. Trend: 2023 $227 · 2024 $16 · 2025 $671
Food & beverage: $671
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $136 |
| Syndax Pharmaceuticals, Inc. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| GENZYME CORPORATION | 1 | $117 |
| Incyte Corporation | 1 | $78 |
| Pharmacosmos Therapeutics Inc. | 2 | $66 |
| Caris MPI, Inc. | 1 | $24 |
Products named: ICLUSIG, IMFINZI, SARCLISA, Jakafi, MONOFERRIC, MI CANCER SEEK.
Industry payments across MI — which companies pay providers there.
